SM

Shahzad Malik

General Partner at Advent Life Sciences

London, England

Investor
VC

Invests in

Stages:

Series B
Series A

Sectors:

Diagnostics
Medical Devices
Pharmaceuticals
BioTech
London

Locations:

London
  • Min Investment:

    $25,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,000,000.00

Skills

Venture Capital
Private Equity
Start-ups
Growth Capital
Entrepreneurship
Mergers
Corporate Development
Lifesciences
Biotechnology
Valuation
Commercialization
Investor Relations
Emerging Markets
IPO
Medical Devices
Board of Directors
Joint Ventures
Capital Raising
Angel Investing
Deal Sourcing

Education

  • Uo

    MB,BChir

    University of Cambridge

    (1988 - 1990)

  • Uo

    MA

    University of Oxford

    (1985 - 1988)

Lists including Shahzad

AT
AS
AT
AH

All Series A Investors

14748 people

Investments

Moximed

Series C

Total Funding: $200M

MiroBio

Series A

Total Funding: $130M

Wondr Medical

Seed

Total Funding: $15M

Proximie

Series C

Total Funding: $120M

Acutus Medical

Series A

Total Funding: $110M

Versartis

Series B

Total Funding: $130M

Conatus Pharmaceuticals

Series A

Total Funding: $50M

Work Experience

AL
Advent Life Sciences LLP

1999

  • General Partner

    1999

MT
MQ: Transforming Mental Health

2019

  • Chair Of The Board Of Trustees

    2019

M&
McKinsey & Company

1997 - 1999

  • Associate

    1997 - 1999

N
NHS

1991 - 1997

  • Interventional Cardiologist

    1991 - 1997

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.